Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medicover Board/Management Information 2017

Oct 23, 2017

2943_rns_2017-10-23_6a2282ad-949c-42d6-9d23-bd7085c62486.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

Press Release Stockholm 23 October 2017

MEDICOVER'S NOMINATION COMMITTEE FOR THE AGM 2018

Medicover publishes the nomination committee's composition for the AGM in 2018.

The nomination committee, which is appointed in accordance with the principles adopted by the annual general meeting on 10 March 2017, consists of:

  • Fredrik Stenmo, representing the af Jochnick family's total shareholding
  • Per Colleen, Fjärde AP-Fonden
  • Gunnar Blix, Tredje AP-Fonden

The Board Medicover AB (publ)

For more information, please visit:

https://investors.medicover.com/

Shareholders who wish to submit proposals to the nomination committee for the annual general meeting on 26 April 2018 can do so by e-mail to [email protected] or:

Medicover AB

Att: Nomination Committee/General Legal Counsel

Box 55720

114 83 Stockholm

Proposals should be submitted to the nomination committee before 8 March 2018.

For further information, please contact:

Paula Treutiger, Director Corporate Communication & Investor Relations

Phone: +46 73 366 65 99 [email protected]

Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities and laboratories and the largest markets are Poland and Germany. In 2016, Medicover had revenues around €0.5 billion and 14,400 employees. For more information, go to www.medicover.com